Table 1.
Molecule | Role | References |
---|---|---|
VEGF | Stimulate migration of myeloid cells to metastatic niche | [9] |
Angiogenesis | [3] [10] [8] |
|
Chemoattractant for macrophages (VEGFA) | [3] | |
Stimulate lymphangiogenesis (VEGFA, C, D) | [3] [8] [18] |
|
TNF-α | Stimulate migration of myeloid cells to metastatic nice | [9] [10] |
Pro-inflammatory | [9] [10] |
|
Extravasation | [6] | |
Immunosuppression | [5] | |
TGF-β | Stimulate migration of myeloid cells to metastatic nice | [9] |
TME remodeling | [11] | |
Pro-inflammatory | [9] [10] |
|
Macrophage polarization to M2 phenotype | [5] | |
Fibroblast activation | [10,19] | |
CXCL5 | Liver metastasis | [11] |
CCR6 | Liver metastasis | [11] |
Tumor cell recruitment | [16] | |
EGF | TME remodeling | [11] |
IGF | TME remodeling | [11] |
Glutamate | Liver metastasis | [12] |
ICAM and VCAM | Cell adhesion | [6] |
Extravasation | [6] | |
MMP | TME remodeling (MMP-2, -9, -13) | [11] |
HIF-1 | Formation of pre-metastatic nice | [9] |
Extravasation | [8] | |
CXCR4 | Local tumor expansion | [3] |
Extravasation | [3] | |
CXCL2 CXCL3 CXCL8 |
Hepatic metastasis (CXCL2) | [3] |
Promote tumor vascularization | [3] [11] |
|
CTLA-4 | Immunosuppression | [5] |
Macrophage polarization to M2 phenotype | [5] | |
PD-1 | Immunosuppression | [5] |
PDL-1 | CD8+ T cell suppression | [9] |
CXCL1 CXCL2 |
MDSC recruitment | [5] |
T-cell inhibition | [5] | |
CCL5 | Liver metastasis | [3] |
T-cell inhibition | [5] | |
ROS | T-cell inhibition | [5] |
ARGINASE | T-cell inhibition | [5] |
IL2 | Immunosuppression | [5] |
Macrophage polarization to M2 phenotype | [5] | |
IL10 | Immunosuppression and macrophage polarization to M2 phenotype | [5] |
IL6 | Promote extravasation from lymphatic vessels | [8,20] |
Inflammation | [8] | |
CCL20 | Liver metastasis (attraction of CCR6+ tumor cells) | [16] |
CEA | Liver metastasis | [17] |
INTEGRINS | Cell adhesion | [6] |
Liver metastasis (α6β1, α6β4, α2β1, αvβ6, αvβ5) | [15] [10] [21] |
|
OSTEOPONTIN | Liver metastasis | [15] |